Category Archives: Industry

Industry news on LLLT, Low Level Laser Therapy, Cold Laser, Laser Biostimulation, LEPT Low Energy photon Therapy, LILT Low Intensity Laser therapy, Photobiomodulation, Photostimulation, Laser Therapy

A new study conducted by St. Jude Nursing Research using Photobiomodulation

St Jude Hospital is the world’s leading research centre for catastrophic diseases in children. They just published a story on our Photobiomodulation treatment of Oral Mucositis, a common side-effect of chemotherapy or radiotherapy treatments.

Shining a Light on Mucositis

A new study conducted by St. Jude Nursing Research uses a painless therapy to help children avoid a common side effect of bone marrow transplantation.

Read the full article at www.stjude.org

Posted in Industry, Research | Leave a comment

James Carroll received the T.H. Maiman Award for outstanding research during the Academy for Laser Dentistry award ceremony

James Carroll, CEO of THOR PhotomedicineJames Carroll, CEO of THOR Photomedicine, a speaker at the 2019 CSSP Spring Leadership Workshop, received the T.H. Maiman Award for outstanding research during the Academy for Laser Dentistry’s (ALD) award ceremony at their annual conference (April 8-10), during which Red Light Therapy’s role in revolutionizing medical care was showcased. Kathleen Maiman, widow of Laser inventor Theodore Maiman, presented the award.

Carroll, a Fellow of the Royal Society of Medicine, is considered the world’s leading proponent of using Red Light Therapy, also known as Photobiomodulation (PBM). He has written or co-authored twenty-four academic papers and co-authored four books on the subject.

Carroll is working with 36 medical institutions, including Harvard Medical School, St. Jude Children’s Hospital, Veterans’ Hospitals, and the UK National Health Service (NHS), on using PBM for treating a range of conditions such as traumatic brain injury, the side effects of cancer treatments, … Continue reading

Posted in Conference, Industry, James in Action, Special Feature | Leave a comment

American Oncology Network to be First Medical Oncology Network in United States to Offer THOR® Light Therapy at The Center for Cancer and Blood Disorders

New technology helps prevent oral mucositis for head and neck cancer patients undergoing radiation or chemoradiation

THE CENTER FOR CANCER AND BLOOD DISORDERS
Fort Myers, Fla. & Bethesda, Md., March 08, 2021 (GLOBE NEWSWIRE) — The Center for Cancer and Blood Disorders (CCBD), an American Oncology Network (AON) partner, is pleased to announce it is now offering THOR® Photobiomodulation (PBM) therapy for the prevention and treatment of mouth sores in cancer therapy patients. Patients can now receive light therapy at both office locations in Maryland, Bethesda at 6410 Rockledge Drive, Suite 660 and in Germantown at 19735 Germantown Road, Suite 255.

The positive effects of PBM therapy on oral mucositis have been reported in 42 randomized controlled trials and nine systematic reviews, reducing the incidence of severe mucositis. Guidelines issued by the Multinational Association … Continue reading

Posted in Industry, Special Feature, THE FUTURE OF LLLT | Leave a comment

James Carroll interviewed by Linda Bailey

James Carroll, Founder and CEO of Thor Photomedicine interviewed by Linda Bailey, owner of Total You Health.

James discusses facts and myths about the therapy. From why red light is the best for healing of all the colors in the light spectrum, to when he thinks PBM will become more mainstream, he sheds light on where this therapy is today compared to other alternative therapies. Listen to the exciting advances being made and big news about insurance coverage!

A 1 hour video interview.

View current photobiomodulation therapy training dates in your location.

Posted in Industry, Interviews, James in Action, Video of the Week | Leave a comment

WVU Medicine Children’s, WVU Cancer Institute work to reduce pain in pediatric cancer patients

Chemotherapy is difficult for any child, but when it causes mucositis, a painful side effect that causes ulcers to form in the mouth, it gets even harder. These children often require more pain medications and longer hospital stays.

Ben Wilson, 11, of Dilliner, Pa., was one of those patients. He was diagnosed with Ewing sarcoma. The chemotherapy regimen he was on was known to cause mucositis, but it was his best course of treatment. When he developed mucositis, his mother, Alison Wilson, talked to Dr. Hannah Hazard-Jenkins, director of the WVU Cancer Institute, about the trouble Ben was having with sores in his mouth and how difficult it was to maintain a lengthy mouthwash regimen to try to treat them.

“We tried some preventive treatments, including cold therapy, where you have them eat a lot of ice and do a series of seven mouthwashes, ” Alison Wilson said. “The cold therapy didn’t help much. Plus, it’s hard to use seven mouthwashes in a day, especially if you’re a kid, and they don’t taste very good.”

Hazard-Jenkins reached out to Dr. … Continue reading

Posted in Industry | Leave a comment

Managing Oral Mucositis with PBM

Annette Quinn, RN, MSN | UPMC Hillman Cancer Centers, Pittsburgh, Pennsylvania

This session focuses on the use of photobiomodulation (PBM) in the management of oral mucositis in oncology patients.

Educational Objectives

  • Identify the prevalence of oral mucositis (OM) in the oncology population.
  • Describe the benefits of PBM in the management of OM in this population.
  • Identify barriers to implementing a PBM program in oncology

Read more: https://www.thorlaser.com/oralmucositis/

View current photobiomodulation therapy training dates in your location.

Disclaimer: These comments by healthcare professionals and their patients are solely their own. They are uncompensated personal stories about how they have used, or been impacted by, light therapy. These uses have not been reviewed or cleared by FDA.

Posted in Conference, Industry, Research, Video of the Week | Leave a comment

ALD PBM Symposium – October 14, 2020 Session

James Carroll, FRSM, CEO | THOR Photomedicine Ltd, Chesham, Buckinghamshire, United Kingdom

Photobiomodulation for Orofacial Pain

Photobiomodulation (PBM) has many applications in dentistry with clinical trial evidence published for a wide range of painful pathologies, including postoperative pain, aphthous ulcers, orthodontic pain, burning mouth syndrome, postherpetic neuralgia, trigeminal neuralgia, stomatitis, oral mucositis, dentin hypersensitivity, temporomandibular disorder (TMD), and neck pain. PBM can also be used to desensitize teeth and even induce anesthesia.

How does PBM do this, what is the evidence, and how does one treat a patient? What treatment parameters (wavelength, power, beam area, irradiance, pulses, treatment time, energy and fluence) are required for a successful treatment? How much PBM is enough, how much is too much, how many treatments are needed, what intervals are required between treatment? What are the contraindications and treatment reactions, and are there any adverse effects? This presentation will address these issues.

Educational Objectives

Posted in Industry, Research, Video of the Week | 1 Comment